Literature DB >> 28506145

Areas of Control Desired by Patients and Families Referred to Hospice Care: Perspectives of Hospice Admissions Staff.

Hyunjin Noh1.   

Abstract

Sense of control in end-of-life (EOL) care plays a critical role in the patient's well-being. However, little is known about the areas of control essential to patients and families at a specific time point in the illness trajectory: when patients stop curative treatments and are referred to hospice. This study qualitatively explored such areas. Sixteen admissions staff members from four hospice agencies were interviewed about their perceptions of areas in which patients and families worried about losing control by accepting hospice. The thematic analysis revealed four areas of control: changes to medical care, health care provider changes, use of life-sustaining treatments, and daily life. Participants of this study put a great emphasis on consistently communicating their willingness to honor patients' and families' control over their care decisions and lives. Future research should examine control in EOL care among diverse populations and effectiveness of hospice staff's strategies to address desire for control.

Entities:  

Keywords:  control; end-of-life; hospice

Mesh:

Year:  2017        PMID: 28506145     DOI: 10.1177/0733464817709531

Source DB:  PubMed          Journal:  J Appl Gerontol        ISSN: 0733-4648


  2 in total

1.  What do Future Hospice Patients Expect of Hospice Care: Expectations of Patients in the Palliative Phase Who Might be in Need of Hospice Care in the Future: A Qualitative Exploration.

Authors:  Merel van Klinken; Everlien de Graaf; Rick Bressers; Remco Koorn; Frederieke van der Baan; Saskia Teunissen
Journal:  Am J Hosp Palliat Care       Date:  2019-12-09       Impact factor: 2.500

2.  "That Little Bit of Time": Transition-to-Hospice Perspectives From Hospice Staff and Bereaved Family.

Authors:  Sarah H Cross; Janel R Ramkalawan; Jackie F Ring; Nathan A Boucher
Journal:  Innov Aging       Date:  2022-01-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.